Impact of the Tohoku Earthquake

The Company's Official Page[PDF]
http://www.ds-pharma.com/pdf_view.php?id=74
Back To Previous Page


March 17, 2011


Company name: Dainippon Sumitomo Pharma Co., Ltd.
Representative: Masayo Tada, President
(Securities Codes: 4506, 1st Section of TSE and OSE)
Contact: Atsuko Higuchi, Director, Corporate Communications
(Phone: +81-6-6203-1407)


Impact of the Tohoku Earthquake


Dainippon Sumitomo Pharma Co., Ltd. (Headquarters: Osaka, Japan; President: Masayo Tada;
hereinafter called “DSP”) expresses its deepest sympathy for victims of the earthquake and our

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

    この内容でのリリース掲載はまだ無いか、集計されておりません。

Most Popular: Pharmaceuticals

1. Eisai Receives Action Letter on Fospropo...
Eisai Co., Ltd. 2008/07/26
2. Dainippon Sumitomo Pharma Group Contribu...
Sumitomo Pharma Co., Ltd. 2011/03/31
3. Kaken licenses out Fiblast® Spray in...
Kaken Pharmaceutical Co.,Ltd. 2005/12/20
4. GlaxoSmithKline and Kaken Pharmaceutical...
Kaken Pharmaceutical Co.,Ltd. 2002/12/16
5. KAKEN PHARMACEUTICAL Start Operations of...
Kaken Pharmaceutical Co.,Ltd. 2002/03/26

Latest News: Sumitomo Pharma Co., Ltd.


Most Popular: Sumitomo Pharma Co., Ltd.

1. Supplementary Financial Data ...
2009/05/11

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

Home

Terms & Conditions

TwitterFacebook

About Us